No Data
No Data
Immuneering Slides As Insider Purchases Lose Another US$186k
Needham Maintains Immuneering(IMRX.US) With Buy Rating, Cuts Target Price to $12
Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX) and Palatin Technologies (PTN)
Immuneering Announces Clinical Supply Agreement With Regeneron
Express News | Immuneering Corp - to Sponsor Studies, Regeneron to Provide Libtayo
Express News | Immuneering Announces Clinical Supply Agreement With Regeneron Pharmaceuticals to Evaluate Imm-1-104 in Combination With Libtayo® (Cemiplimab)